(Q45878342)

17 December 2017

title

Systemic Insulin-like growth factor-1 reverses hypoalgesia and improves mobility in a mouse model of diabetic peripheral neuropathy (English)

1 reference

17 December 2017

author name string

Qiuming Chu

1

1 reference

17 December 2017

Rod Moreland

2

1 reference

17 December 2017

Nelson S Yew

3

1 reference

17 December 2017

Joseph Foley

4

1 reference

17 December 2017

Robin Ziegler

5

1 reference

17 December 2017

Ronald K Scheule

6

1 reference

17 December 2017

publication date

10 June 2008

1 reference

17 December 2017

published in

Molecular Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

1400-1408

1 reference

17 December 2017

The health care costs of diabetic peripheral neuropathy in the US.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

The neuropathic diabetic foot

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Morbidity of hypoglycemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Hypoglycemic neuropathy.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

The role of growth factors in diabetic peripheral neuropathy.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Alteration of the gene and protein levels of insulin-like growth factors in streptozotocin-induced diabetic male rats.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Diabetes-induced suppression of IGF-1 and its receptor mRNA levels in rat superior cervical ganglia

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Neuropathy in diabetic BB/Wor rats treated with insulin implants

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Beta cell expression of IGF-I leads to recovery from type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Management of neuropathy and foot problems in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Insulin-like growth factor-I promotes myelination of peripheral sensory axons

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

IGF-I promotes peripheral nervous system myelination

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Regulation of rat Schwann cell Po expression and DNA synthesis by insulin-like growth factors in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Identification of androgen response elements in the insulin-like growth factor I upstream promoter

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Transient siRNA-mediated attenuation of liver expression from an alpha-galactosidase A plasmid reduces subsequent humoral immune responses to the transgene product in mice

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Cloning of infectious adeno-associated virus genomes in bacterial plasmids

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.115

7 January 2021

Identifiers

DOI

10.1038/MT.2008.115

1 reference

17 December 2017

1 reference

17 December 2017